Restoring vision using a special light-sensing protein
A new strategy for vision restoration based on melanopsin transduction mechanisms
This project aims to help people with severe retinal diseases regain their sight by making a natural light-sensing protein in their eyes work faster.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Baylor College of Medicine NIH-funded |
| Lab location | 1 site (Houston, United States) |
| Project ID | NIH-11123139 on NIH RePORTER |
What this research studies
For people who have lost their vision due to severe retinal diseases, the light-sensing cells in their eyes (rods and cones) are often gone. However, other cells in the eye called ipRGCs still have a light-sensing protein called melanopsin. The problem is that melanopsin reacts to light very slowly, which means it can't create clear images. This project is working to speed up how melanopsin responds to light by adjusting other parts of the cell's light-sensing system, with the goal of improving vision in eyes where the main light sensors are no longer working.
Who could benefit from this research
Good fit: This research is relevant for patients experiencing irreversible vision loss due to photoreceptor degeneration in retinal diseases.
Not a fit: Patients with other causes of vision loss not related to retinal photoreceptor degeneration may not directly benefit from this specific approach.
Why it matters
Potential benefit: If successful, this work could lead to new treatments that restore image-forming vision for individuals with advanced retinal degeneration.
How similar studies have performed: Previous work has shown that melanopsin's light response can be accelerated, suggesting a promising direction for this novel vision restoration approach.
Where this research is happening
Houston, United States
- Baylor College of Medicine — Houston, United States (Active)
Researchers
- Principal investigator: Jiang, Zheng — Baylor College of Medicine
- Study coordinator: Jiang, Zheng
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.